预测放射性碘难治性分化型甲状腺癌的评分系统与简易列线图:一项回顾性研究
该回顾性研究纳入404例接受治疗后全身碘扫描和18F-FDG PET/CT的转移性分化型甲状腺癌患者,分析放射性碘难治性(RR-DTC)的预测因素。多因素分析确定诊断年龄≥48岁、手术与碘-131治疗间复发、18F-FDG摄取及转移部位为独立预测因素,据此建立评分系统与列线图,评分≥10分预测RR-DTC的AUC为0.898,列线图c-Index为0.9。
要点
- 诊断年龄≥48岁、手术与碘-131治疗间复发、18F-FDG摄取及转移部位是RR-DTC的独立预测因素。
- 评分系统以10分为界值预测RR-DTC的AUC为0.898,高于任一单一独立预测因素。
- 列线图纳入上述四因素,c-Index为0.9,作者认为该模型有助于建立主动监测或适当治疗策略。
核心结论
- 基于四个因素的预测模型对RR-DTC有较好的预测能力,评分≥10分是预测RR-DTC的最佳界值。
- 列线图模型具有较好的预测能力与稳定性,作者认为该模型可能有助于为RR-DTC病例建立主动监测或适当的治疗策略。
研究设计与样本
- 回顾性研究,纳入404例接受治疗后全身碘扫描和18F-FDG PET/CT的转移性分化型甲状腺癌患者。
- 从病历获取RR-DTC与非RR-DTC病例的临床特征与分子特征数据,经单因素分析筛选预测因素,多因素分析获得独立预测因素,并按相应OR值建立评分系统与简易列线图。
主要发现
- 诊断年龄≥48岁与RR-DTC独立相关(OR 1.037,95%CI 1.007-1.069)。
- 手术与碘-131治疗之间复发与RR-DTC独立相关(OR 7.362,95%CI 2.388-22.698)。
- 18F-FDG摄取与RR-DTC独立相关(OR 39.534,95%CI 18.590-84.076)。
- 转移部位与RR-DTC独立相关(OR 4.365,95%CI 1.593-11.965)。
- 评分系统以10分为界值时AUC为0.898,判别力高于任一单一独立预测因素;列线图c-Index为0.9。
关键数值与推荐
- 评分系统预测RR-DTC的界值为10分,AUC为0.898。
- 列线图纳入诊断年龄≥48岁、手术与碘-131治疗间复发、18F-FDG摄取及转移部位,c-Index为0.9。
临床怎么用
- 作者认为该预测模型可能有助于为RR-DTC病例建立主动监测或适当的治疗策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Differentiated thyroid carcinoma (DTC) originates from abnormal follicular cells and accounts for approximately 90-95% of thyroid malignancies. The diagnosis of radioiodine refractory DTC (RR-DTC) is based on clinical evolution and iodine uptake characteristics rather than pathological characteristics. Thus, it takes a long time to become apparent, and the definition of RR-DTC covers multiple aspects. We aimed to analyze the clinical and molecular imaging characteristics of patients with RR-DTC and identify independent predictors to develop an RR-DTC scoring system and a simple nomogram for predicting the probability of RR-DTC. We reviewed the data of 404 patients with metastatic DTC who underwent both post-RAI WB therapy scintigraphy and 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography. Data on the clinical features and molecular characteristics of RR-DTC and non-RR-DTC cases were obtained from medical records. We screened for predictors using univariate analyses, obtained independent predictors through multivariate analyses, and then established a scoring system and a simple nomogram for predicting RR-DTC according to the corresponding odds ratio (OR) values. RESULTS: Diagnosis at age ≥ 48 years (OR, 1.037; 95% confidence interval [CI], 1.007-1.069), recurrence between the operation and iodine-131 treatment (OR, 7.362; 95% CI 2.388-22.698), uptake of 18F-FDG (OR, 39.534; 95% CI 18.590-84.076), and the metastasis site (OR, 4.365; 95% CI 1.593-11.965) were highly independently associated with RR-DTC. We established a scoring system for predicting RR-DTC, showing that the area under the receiver operating characteristic curve (AUC) with a cutoff value of 10 points (AUC = 0.898) had a higher discernibility than any other single independent predictor. The risk factors of RR-DTC in nomogram modeling include diagnosis at age ≥ 48 years, recurrence between the operation and iodine-131 treatment, uptake of 18F-FDG, and the site of metastasis. The concordance index (c-Index) of the nomogram was 0.9. CONCLUSIONS: We demonstrated that a predictive model based on four factors has a good ability to predict RR-DTC. An index score ≥ 10 points was found to be the optimal index point for predicting RR-DTC. Moreover, this nomogram model has good predictive ability and stability. This model may help establish an active surveillance or appropriate treatment strategy for RR-DTC cases.
引用
- Liu Y, Wang Y, Zhang W, et al. Scoring system and a simple nomogram for predicting radioiodine refractory differentiated thyroid cancer: a retrospective study. EJNMMI Res. 2022. PMID: 35904608. doi:10.1186/s13550-022-00917-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。